Search Results 491-500 of 16321 for VEO-IBD
William A. Faubion Jr., M.D., who leads the Immuno-Epigenetics Lab, is a mentor and director for several education programs at Mayo Clinic.
About this study. Investigator plans to examine the gastrointestinal (GI) physiologic profile of Teduglutide, a Glucagon-like Peptide 2 Analog as a possible ...
This type of cancer starts in the small intestine. Find out more about symptoms and treatments, including surgery, chemotherapy and targeted therapy.
This program will provide a comprehensive review of state-of-the-art 2-D,. Doppler and transesophageal echocardiography with a strong emphasis on.
Congestive heart failure (CHF) affects nearly 5 million Americans and claims more than 300,000 lives annually. A primary pathophysiologic mechanism in this ...
Robotic systems can help surgeons increase precision, flexibility and control for many procedures. Learn about the advantages and availability of ...
- Active inflammatory bowel disease (i.e., patients requiring medical interventions or who are symptomatic). - Prior pelvic RT for any reason. - Documented ...
Jolly is a gentleman with acute kidney injury. Monitoring is very important with these patients. Usually hospital stays on this or at least three to five days ...
Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...
About this study. The purpose of this study is to evaluate the safety and tolerability of multiple subcutaneous injections of a mutanome-directed active ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.